Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
30 hedge funds and large institutions have $9.25M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
15,800% more call options, than puts
Call options by funds: $159K | Put options by funds: $1K
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
11% more funds holding
Funds holding: 27 → 30 (+3)
23% less capital invested
Capital invested by funds: $12M → $9.25M (-$2.76M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.06M |
| 2 |
Renaissance Technologies
New York
|
+$600K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$242K |
| 4 |
VF
Virtu Financial
New York
|
+$129K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$46.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$5.14M |
| 2 |
JP Morgan Chase
New York
|
-$103K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$56.3K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$8K |
| 5 |
BlackRock
New York
|
-$3.35K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WEC
26
Winslow Evans & Crocker
Boston,
Massachusetts
| $2K | – | – | – |
|
|
PCM
27
Princeton Capital Management
Red Bank,
New Jersey
| $1K | – | – | – |
|
|
AC
28
Armistice Capital
New York
| – | -$5.14M | -13,843 | Closed |
|
|
29
JP Morgan Chase
New York
| – | -$103K | -277 | Closed |
|
|
30
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$8K | -22 | Closed |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| – | +$335 | +1 | New |
|
|
WAM
32
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | +$335 | +1 | New |
|
FRTX Hedge Fund Activity: Q1 2019 in Review
30 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2019, worth a combined $9.25M — down 23% from $12M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FRTX positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was BVF Inc, adding an estimated $1.06M. The largest seller was Armistice Capital, exiting entirely with an estimated $5.14M sold.
- 30 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2019, up from 27 in Q4 2018.
- Funds reported $9.25M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2019, down 23% quarter-over-quarter.
- 6 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2019 and 3 closed out, a net change of +3 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2019 was BVF Inc, an estimated $1.06M added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2019 was Armistice Capital, an estimated $5.14M sold.
Based on aggregated 13F filings for Q1 2019.